The human and economic costs of delayed interventions provide a motivation for the use of all available treatments—here, we have suggested that heterogeneity in death rates can make conclusions about mortality from ivermectin hard to draw on the basis of small population studies such as that of Barkwell and Shields; in particular, we strongly advise against over-interpretation of very small p -values that can arise as ‘highly significant’ [ 60 ] as a specific instance of known problems with the use of p -values in general [ 61 ].
← all excerpts
Scabies in residential care homes: Modelling, inference and interventions for well-connected population sub-units.
1
—
—